The metabolism of orally administered L-dopa in Parkinson patients.
D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D006801:Humans; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy*; D010648:Phenylacetates / Q000378:metabolism; D011736:Pyridoxine / Q000627:therapeutic use
D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D011736:Pyridoxine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine